The companys lead candidate (NPI-001), manufactured using a patented process, is the amide form of N-acetyl-L-cysteine (NAC)
Cancellation Policy Following the administration of treatments, all treatments are non-refundable, and all sales are final
Silva3, Kate Barry2, Ali Fathi4, Simin Maleknia4, Paul Young1,3,5, Daniela Traini1,2, Hui Xin Ong1,2,3 1Respiratory Technology, The Woolcock Institute of Medical Research, Sydney, NSW 2037, Australia 2Macquarie Medical School, Faculty of Medicine, Health, and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia 3Ab Initio Pharma Pty Ltd, Sydney, NSW, Australia 4Tetratherix Technology Pty Ltd, Sydney, NSW, Australia 5Department of Marketing, Business School, Macquarie University, Sydney, NSW 2109, Australia Summary: In this study, a novel synthetic thermosensitive polymer, poly(Nisopropylacrylamide)co(polylactide/2hydroxy methacrylate)co(oligo (ethylene glycol), denoted as TP, is presented as a promising drug carrier for sustained intranasal drug delivery
Can constipation interfere with liver detoxification
Inhibition of CCL28/CCR10-Mediated eNOS downregulation improves skin wound healing in the obesity-induced mouse Model of Type 2 Diabetes